Latest Cancer News

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer (09-25-2017)
Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this... Continue Reading

FDA Adds Two Roche Multiple Myeloma Studies Evaluating Checkpoint Inhibitors to List of Partial Clinical Holds Over Safety Concerns (09-25-2017)
Alarmed that an imbalance in deaths among patients taking a combination of Keytruda (pembrolizumab) with Celgene’s Pomalyst and Revlimid could represent a threat in that whole class of checkpoint comboinations,... Continue Reading

Alecensa Appears Superior to Xalkori in ALK positive NSCLC Involving the Brain (09-21-2017)
The results from two separate clinical studies comparing Alecensa® (alectinib) to Xalkori (crizotinib) presented at the European Society for Medical Oncology in Madrid demonstrate that Alecensa®  s... Continue Reading

More Cancer News

Locations

Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611